Literature DB >> 6520178

Determination of salbutamol in human serum by reversed-phase high-performance liquid chromatography with amperometric detection.

Y K Tan, S J Soldin.   

Abstract

A simple and sensitive method for the quantitative determination of salbutamol in human serum using reversed-phase ion-pair high-performance liquid chromatography with electrochemical detection is described. The method involves the combined use of Sep-Pak cartridges and ion-pair extraction for sample clean-up, and subsequent separation of salbutamol and the internal standard from interfering compounds on a reversed-phase column. An amperometric detector incorporating a glassy carbon electrode was employed for detection. The inter-assay coefficients of variation at plasma concentrations of 2.0, 6.0 and 20.0 ng/ml were 7.3%, 7.2% and 8.5%, respectively (n = 20). The minimum detection limit was 400 pg/ml from a 0.5-ml sample of serum. The method can be readily utilised for clinical pharmacokinetic studies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6520178     DOI: 10.1016/s0378-4347(00)84724-6

Source DB:  PubMed          Journal:  J Chromatogr


  4 in total

Review 1.  Salbutamol in the 1980s. A reappraisal of its clinical efficacy.

Authors:  A H Price; S P Clissold
Journal:  Drugs       Date:  1989-07       Impact factor: 9.546

Review 2.  Enantioselective disposition of albuterol in humans.

Authors:  D W Boulton; J P Fawcett
Journal:  Clin Rev Allergy Immunol       Date:  1996       Impact factor: 8.667

3.  Effects of inhaled salbutamol in exercising non-asthmatic athletes.

Authors:  C Goubault; M C Perault; E Leleu; S Bouquet; P Legros; B Vandel; A Denjean
Journal:  Thorax       Date:  2001-09       Impact factor: 9.139

4.  Pharmacokinetics and absolute bioavailability of salbutamol in healthy adult volunteers.

Authors:  D A Goldstein; Y K Tan; S J Soldin
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.